MedPath

Blood Glucose Management in Diabetic COVID19 Patients

Not Applicable
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Registration Number
CTRI/2020/11/029059
Lead Sponsor
A
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Inpatients in General Medicine with diagnosis of COVID 19 infection (Laboratory confirmed)

2. Patients with pre existing diabetes or New onset diabetic patients.

Exclusion Criteria

1. AGE Less than 18 YEARS

2. Acute Myocardial infarction

3. Acute cerebral vascular stroke

4. Pregnant Female

5. Impaired glucose tolerance

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical Deterioration and Control of Blood GlucoseTimepoint: At Baseline, Every 3rd Day till Discharge/Death
Secondary Outcome Measures
NameTimeMethod
1. In hospital stay (Duration and Type of stay-ICU or ward) <br/ ><br>2.Mortality <br/ ><br>3. Effect of glycemic control on level of inflammatory markersTimepoint: At Baseline, Every 3rd Day till Discharge/Death
© Copyright 2025. All Rights Reserved by MedPath